Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD.

Sun J, Wen M, Wang Y, Liu D, Ying W, Wang X.

BMC Med Genet. 2017 Nov 13;18(1):127. doi: 10.1186/s12881-017-0492-6.

2.

Spectrum of imaging findings of chronic granulomatous disease: a single center experience.

Lee M, Lee MS, Lee JS, Ko SY, Jeong SY.

Diagn Interv Radiol. 2017 Nov-Dec;23(6):472-477. doi: 10.5152/dir.2017.17264.

3.

Recent advances in understanding and treating chronic granulomatous disease.

Gennery A.

F1000Res. 2017 Aug 11;6:1427. doi: 10.12688/f1000research.11789.1. eCollection 2017. Review.

4.

Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity.

Thomas DC, Clare S, Sowerby JM, Pardo M, Juss JK, Goulding DA, van der Weyden L, Storisteanu D, Prakash A, Espéli M, Flint S, Lee JC, Hoenderdos K, Kane L, Harcourt K, Mukhopadhyay S, Umrania Y, Antrobus R, Nathan JA, Adams DJ, Bateman A, Choudhary JS, Lyons PA, Condliffe AM, Chilvers ER, Dougan G, Smith KG.

J Exp Med. 2017 Apr 3;214(4):1111-1128. doi: 10.1084/jem.20161382. Epub 2017 Mar 28.

5.
6.

The intimate and controversial relationship between voltage-gated proton channels and the phagocyte NADPH oxidase.

DeCoursey TE.

Immunol Rev. 2016 Sep;273(1):194-218. doi: 10.1111/imr.12437. Review.

7.

Neutrophil-Epithelial Interactions: A Double-Edged Sword.

Parkos CA.

Am J Pathol. 2016 Jun;186(6):1404-16. doi: 10.1016/j.ajpath.2016.02.001. Epub 2016 Apr 12. Review.

8.

Salt, chloride, bleach, and innate host defense.

Wang G, Nauseef WM.

J Leukoc Biol. 2015 Aug;98(2):163-72. doi: 10.1189/jlb.4RU0315-109R. Epub 2015 Jun 5. Review.

9.

Chronic granulomatous disease presenting as aseptic ascites in a 2-year-old child.

Moreau JF, Ozolek JA, Lin PL, Green TD, Cassidy EA, Venkat VL, Buchert AR.

Case Reports Immunol. 2013;2013:927897. doi: 10.1155/2013/927897. Epub 2013 Jan 28.

10.

NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives.

McCann SK, Roulston CL.

Brain Sci. 2013 Apr 22;3(2):561-98. doi: 10.3390/brainsci3020561.

11.

Molecular identification of bacterial DNA in the chorioretinal scars of chronic granulomatous disease.

Wang Y, Marciano BE, Shen D, Bishop RJ, Park S, Holland SM, Chan CC.

J Clin Immunol. 2013 Jul;33(5):917-24. doi: 10.1007/s10875-013-9899-9. Epub 2013 May 1.

12.

NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity.

Han W, Li H, Cai J, Gleaves LA, Polosukhin VV, Segal BH, Yull FE, Blackwell TS.

J Immunol. 2013 May 1;190(9):4786-94. doi: 10.4049/jimmunol.1201809. Epub 2013 Mar 25.

13.

Chronic granulomatous disease.

Holland SM.

Hematol Oncol Clin North Am. 2013 Feb;27(1):89-99, viii. doi: 10.1016/j.hoc.2012.11.002. Epub 2012 Nov 22. Review.

14.

Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling.

Al Ghouleh I, Khoo NK, Knaus UG, Griendling KK, Touyz RM, Thannickal VJ, Barchowsky A, Nauseef WM, Kelley EE, Bauer PM, Darley-Usmar V, Shiva S, Cifuentes-Pagano E, Freeman BA, Gladwin MT, Pagano PJ.

Free Radic Biol Med. 2011 Oct 1;51(7):1271-88. doi: 10.1016/j.freeradbiomed.2011.06.011. Epub 2011 Jun 14. Review.

15.

Residual NADPH oxidase and survival in chronic granulomatous disease.

Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, Uzel G, DeRavin SS, Priel DA, Soule BP, Zarember KA, Malech HL, Holland SM, Gallin JI.

N Engl J Med. 2010 Dec 30;363(27):2600-10. doi: 10.1056/NEJMoa1007097.

16.

Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.

Kang PB, Lidov HG, White AJ, Mitchell M, Balasubramanian A, Estrella E, Bennett RR, Darras BT, Shapiro FD, Bambach BJ, Kurtzberg J, Gussoni E, Kunkel LM.

Muscle Nerve. 2010 Jun;41(6):746-50. doi: 10.1002/mus.21702.

17.

Nox proteins in signal transduction.

Brown DI, Griendling KK.

Free Radic Biol Med. 2009 Nov 1;47(9):1239-53. doi: 10.1016/j.freeradbiomed.2009.07.023. Epub 2009 Jul 21. Review.

18.

The intimate and mysterious relationship between proton channels and NADPH oxidase.

Musset B, Cherny VV, Morgan D, DeCoursey TE.

FEBS Lett. 2009 Jan 5;583(1):7-12. doi: 10.1016/j.febslet.2008.12.005. Epub 2008 Dec 10.

19.

Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry.

Jones LB, McGrogan P, Flood TJ, Gennery AR, Morton L, Thrasher A, Goldblatt D, Parker L, Cant AJ.

Clin Exp Immunol. 2008 May;152(2):211-8. doi: 10.1111/j.1365-2249.2008.03644.x.

20.

An unusual cause of granulomatous disease.

McLean-Tooke AP, Aldridge C, Gilmour K, Higgins B, Hudson M, Spickett GP.

BMC Clin Pathol. 2007 Mar 2;7:1.

Supplemental Content

Support Center